Yang Sun^1* and James R. Cook, MD, PhD²

¹Clinical Pathology, Cleveland Clinic, Cleveland, OH
²Cleveland Clinic Foundation, Cleveland, OH

Drorit Merkel, MD^1*, H. Joachim Deeg², Amos Simon, B.A.^3*, Ninette Amariglio, PhD⁴, Arnon Nagler, M.D.⁵ and Gideon Rechavi, MD, PhD^6*

¹Dept. of Hematology, Sheba Medical Center, Tel Hashomer, Israel
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Laboratory of Hematology, Sheba Medical Center, Tel Hashomer, Israel
⁴Institute of Hematology, Tel-Hashomer, Israel
⁵Division of Hematology, BMT and CBB, Chaim Sheba Medical Center, Tel Hashomer, Israel
⁶Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel

Hadrian Szpurka, MSc, PhD¹, Lukasz P Gondek, MD^1*, Sanjay R Mohan, MD^1*, Eric D Hsi, MD², Karl S Theil, MD², Mikkael A Sekeres, MD, MS³ and Jaroslaw P Maciejewski, MD, PhD¹

¹CHOMT, Experimental Hematology and Hematopoiesis Section, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Clinical Pathology, Cleveland Clinic, Cleveland, OH
³Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Hagop M Kantarjian¹, Susan O'Brien^2*, Farhad Ravandi^2*, Gautam Borthakur^2*, Stefan Faderl^2*, Carlos Bueso-Ramos^2*, Lynne Abruzzo^2*, Sherry Pierce^2*, Jianqin Shan^2*, Jean-Pierre Issa^2* and Guillermo Garcia-Manero^2*

¹The University of Texas M. D. Anderson Cancer Center, Houston, TX
²M.D. Anderson Cancer Center, Houston, TX

Gina Zini, MD, Prof.^1*, Barbara Bain, MD, Prof.^2*, Gianluigi Castoldi, MD, Prof.^3*, José Cortez, PhD, Prof.^4*, Judit Csomor, MD^5*, Edgar Faber, MD, Prof.^6*, Aristoteles Giagounidis^7*, Torsten Haferlach⁸, Petra Kacirkova, MD^9*, Krzysztof Lewandowski, MD, Prof.^10*, Vincenzo Liso^11*, Estella Matutes, MD, PhD^12*, Marc Maynadie, MD, PhD¹³, John Meletis, MD.Prof.^14*, Anna Porwit^15*, M.Leticia Ribeiro, MD^16*, Lydia Sreter, MD., Prof.^5*, Andre Tichelli^17*, Teresa Vallespì, MD.PhD..^18*, Mars B. van 't Veer, MD^19*, Soledad Woessner, MD^20* and Marie-Christine Bene^21*

¹Hematology Laboratory, Università Cattolica Sacro Cuore - Policlinico Gemelli, Rome, Italy
²Department of Haematology, St Mary's Hospital Campus of Imperial College, London, United Kingdom
³Department of Biomedical Sciences, University of Ferrara /S.Anna Hospital, Ferrara, Italy
⁴Faculty of Medical Sciences, New University of Lisbon, Lisboa, Portugal
⁵Department of Pathology and Experimental Cancer Research, 1st Semmelweis University, Budapest, Hungary
⁶Hemato-Oncology, University Hospital Olomouc, Olomuc, Czech Republic
⁷Medizinische Klink II, St. Johannes Hospital, Duisburg, Germany
⁸MLL Munich Leukemia Laboratory GmbH, Munich, Germany
⁹Laboratory of Morphology and Cytochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
¹⁰Medical University of Gdansk, Poland, Gdansk, Poland
¹¹Hematology, Università degli Studi di Bari, Bari, Italy
¹²Section of Haemato-Oncology, The Institute of Cancer Research, London, United Kingdom
¹³Service d'Hématologie Biologique, Plateau Technique de Biologie, Dijon cedex, France
¹⁴First Department of Internal Medicine, University of Athens School of Medicine, Athen, Greece
¹⁵Department of Pathology, Stockholm, Sweden
¹⁶Departamento de Hematologia, Centro Hospitalar de Coimbra, Coimbra, Portugal
¹⁷Hematology, University Hospital of Basel, Switzerland
¹⁸Dpt. Hematology, Vall d'Hebron Hospital, Barcelona, Spain
¹⁹Dpt. Hematology, Erasmus Medical Center, Rotterdam, Netherlands
²⁰Cytological School of Haematology, Hospital del Mar, Barcelona, Spain
²¹GRAALL Group, Lyon, France

David L. Grinblatt, MD¹, Mohit Narang, MD^2*, James M. Malone III, MD³, David A. Sweet^4*, Tim S. Dunne^4* and Kristen A. Sullivan^5*

¹Evanston Northwestern Healthcare, Evanston, IL
²Alliance Hematology Oncology, Westminster, MD
³Oncology-Hematology Medical Associates of the Central Coast, San Luis Obispo, CA
⁴Celgene Corporation, Summit, NJ
⁵Celgene Corporation, Overland Park, KS

Gudrun Göhring, MD^1*, Aristoteles Giagounidis², Carlo Aul^3*, Guntram Büsche, MD^4*, Hans Kreipe, MD^4*, Eva Hellström-Lindberg, MD, PhD⁵, Robert D. Knight, MD⁶ and Brigitte Schlegelberger, MD¹

¹Institute of Cell & Molecular Pathology, Hannover Medical School, Hannover, Germany
²Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany, Duisburg, Germany
³Medical Clinic II, St. Johannes Hospital, Duisburg, Germany
⁴Institute of Pathology, Hannover Medical School, Hannover, Germany
⁵Dept. of Med., Div. of Hem, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
⁶Celgene Corporation, Summit, NJ

Wolfgang R Sperr^1*, Friedrich Wimazal^1*, Michael Kundi^2*, Christian Baumgartner^1*, Thomas Noesslinger³, Anabel Makrai^3*, Reinhard Stauder, MD^4*, Otto Krieger^5*, Michael Pfeilstocker, MD³ and Peter Valent, MD¹

¹Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
²Institute of Environmental Hygiene, Medical University of Vienna, Vienna, Austria
³3rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
⁴University Hospital, Innsbruck, Austria
⁵Department of Internal Medicine I, Hospital Elisabethinen, Linz, Austria

Maria del Mar Mallo^1*, José Cervera, MD, PhD^2*, Julie Schanz^3*, Blanca Espinet, PhD^1*, Esperanza Such^2*, Elisa Luño, MD, PhD^4*, Christian Steidl, MD^3*, María Luisa Martín^5*, Ulrich Germing^6*, Javier Grau, MD^7*, Michael Pfeilstoecker, MD^8*, Jesús M Hernández, MD, PhD^9*, Thomas Noesslinger¹⁰, M.ª José Calasanz, PhD^11*, Peter Valent, MD¹², Rosa Collado, MD, PhD^13*, Christa Fonatsch^14*, Encarna Bureo, MD^15*, Michael Lübbert, MD, PhD^16*, Rafael Ríos, MD, PhD^17*, Reinhard Stauder, MD^18*, Eva Arranz^19*, Barbara Hildebrandt^20*, Marilyn L. Slovak, PhD²¹, Juan Cigudosa, PhD²², Virginie Eclache^23*, Otto Krieger^24*, Carmen Pedro, MD^25*, Marta Salido^1*, Leonor Arenillas, MD^1*, Guillermo Sanz, MD, PhD²⁶, Miguel A. Sanz, MD, PhD²⁷, Ana Valencia^2*, Lourdes Florensa, MD, PhD^1*, Detlef Haase, MD, PhD^3* and Francesc Solé, PhD¹

¹Pathology, Hospital del Mar, Barcelona, Spain
²Servicio de Hematologia, Hospital Univ. La Fe, Valencia, Spain
³Hematology and Oncology, University of Göttingen, Göttingen, Germany
⁴Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain
⁵Genetics, Hospital Universitario 12 de Octubre, Madrid, Spain
⁶Universitatsklinik Dusseldorf, Dusseldorf, Germany
⁷Hematology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
⁸3rd Med. Dept. Hanusch-Hosp., Vienna, Austria
⁹Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
¹⁰3rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
¹¹Genetics, Universidad de Navarra, Pamplona, Spain
¹²Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
¹³Hematology, Consorcio Hospital General Universitario, Valencia, Spain
¹⁴Medical Genetics, Medical University of Vienna, Vienna, Austria
¹⁵Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain
¹⁶Medical Center, University of Freiburg, Freiburg, Germany
¹⁷Hematology, Hospital Universitario Virgen de las Nieves, Granada, Spain
¹⁸University Hospital, Innsbruck, Austria
¹⁹Genetics, Hospital Universitario La Princesa, Madrid, Spain
²⁰Human Genetics, University of Düsseldorf, Düsseldorf, Germany
²¹City of Hope Nat'l Med. Ctr., Duarte, CA
²²Cytogenetics Unit, CNIO, Madrid, Spain
²³Hôpital Avicenne/Université Paris, Bobigny, France
²⁴Department of Internal Medicine I, Hospital Elisabethinen, Linz, Austria
²⁵Hematology, Hospital del Mar, Barcelona, Spain
²⁶Dept. of Hematology, Hospital Universitario La Fe, Valencia, Spain
²⁷On behalf of the PETHEMA, HOVON, PALG, and GATLA cooperative groups, Valencia, Spain

Olga López Villar, MD^1*, Juan LuíS. García, PhD^2*, Fermín. M Sánchez Guijo, MD, PhD^1*, Cristina Robledo^2*, Pilar Hernandez Campo, PhD^3*, Maria Diez Campelo, MD, PhD^1*, Sandra Muntion^3*, Jose Antonio Pérez Simón, MD, PhD^1*, J.F. San Miguel, MD, PhD¹ and MaríA. Consuelo Del Cañizo, MD, PhD^1*

¹Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
²Centro de Investigación del Cancer, Universidad de Salamanca, Salamanca, Spain
³Centro en Red de Terapia Celular de Castilla y León, Salamanca, Spain

Aarthi Shenoy, MD¹, Loretta Pfannes^1*, Francois Wilhelm, MD, Ph.D^2*, Manoj Maniar, Ph.D^2*, Neal Young, MD¹ and Elaine M Sloand, MD¹

¹Nhlbi, NIH, Bethesda, MD
²Onconova Therapeutics, Newtown, PA

Olaf Joachim Hopfer, MD^1*, Martina Komor, PhD^2*, Claudia Freitag^1*, Maximilian Mossner^3*, Dieter Hoelzer, MD, PhD⁴, Eckhard Thiel, MD, PhD⁵ and Wolf-Karsten Hofmann, MD, PhD^6*

¹Hematology and Oncology, Charite Medical School, Berlin, Germany
²Hematology and Oncology, J.W. Goethe University Hospital, Frankfurt/M, Germany
³Charité, Campus Benjamin Franklin, Berlin, Germany
⁴J.W. Goethe University Hospital, Frankfurt/M, Germany
⁵Medizinische Klinik III (Haematologie, Onkologie und Transfusionsmedizin), Charite Campus Benjamin Franklin (Charite Centrum 14), Berlin, Germany
⁶MILE Study Group, on Behalf of European LeukemiaNet (ELN, WP13), Munich, Germany

Valeria Santini, MD^1*, Pierre Fenaux, MD, PhD², Ghulam J Mufti, MBBS, DM, FRCP, FRCPath³, Eva Hellström-Lindberg, MD, PhD^4*, Lewis B. Silverman, MD⁵, Alan List, MD^6*, Steven D. Gore, MD⁷, John F Seymour, MBBS, PhD, FRACP^8*, Jay Backstrom, MD, MPH^9*, David McKenzie, MS^9* and C. L Beach, PharmD^9*

¹Hematology, Azienda Ospedaliera Careggi, Firenze, Italy
²Hématologie Clinique, Assistance Publique - Hôpitaux de Paris, Hôpital Avicenne; Paris 13 University, Bobigny, France
³Department of Haematological Medicine, Kings College London, London, United Kingdom
⁴Karolinska University Hospital, Stockholm, Sweden
⁵Pediatric Oncology, Dana-Farber Cancer Inst., Boston, MA
⁶H Lee Moffitt Cancer Center, Tampa, FL
⁷The Sidney Kimmel Comprehensive Cancer Ctr. at Johns Hopkins, Baltimore, MD
⁸Dept of Haematology, Peter MacCallum Cancer Institute, Australia
⁹Celgene, Overland Park, KS

Jaroslav Cermak, M.D., Ph.D.¹, Dana Mikulenkova, M.D.^2*, Petra Kacirkova, M.D.^2* and Kyra Michalova, Prof., Ph.D.^3*

¹Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
²Clinical Hematology, Institute of Hematology and Blood Transfusion, Praha, Czech Republic
³Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague 2, Czech Republic

Simone Boehrer^1*, Lionel Ades², Nicolas Tajeddine^3*, Lorenzo Galluzzi^1*, Stephane de Botton^4*, Pierre Fenaux⁵ and Guido Kroemer^1*

¹Institut Gustave Roussy, INSERM U848, Villejuif, France
²Hematologie Clinique, Hopital Avicenne, Bobigny, France
³INSERM U848
⁴institut Gustave Roussy, Villejuif, France
⁵Hematologie Clinique, Assistance Publique - Hopitaux de Paris, Hopital Avicenne; Paris 13 University, Bobigny, France

Simone Boehrer^1*, Lionel Ades², Nicolas Tajeddine^3*, Lorenzo Galluzzi^1*, Wolf-Karsten Hofmann^4*, Pierre Fenaux⁵ and Guido Kroemer^1*

¹Institut Gustave Roussy, INSERM U848, Villejuif, France
²Hematologie Clinique, Hopital Avicenne, Bobigny, France
³iNSERM U848
⁴Charite, Campus Benjamin Franklin, Berlin, Germany
⁵Hematologie Clinique, Assistance Publique - Hopitaux de Paris, Hopital Avicenne; Paris 13 University, Bobigny, France

Thorsten Braun^*, Stephane de Botton^*, Anne-Laure Taksin^*, Sophie Park^*, Odile Beyne-Rauzy^*, Sylvie Chevret^*, Michaela Fontenay^*, Bruno Cassinat^*, Anne Lazareth^*, Virginie Eclache^*, Chrisitine Terre^*, Norbert Vey^*, Agnes Guerci^*, Francois Dreyfus^*, Dominique Bordessoule^*, Aspasia Stamatoullas^*, Sylvie Castaigne^*, Pierre Fenaux^* and Lionel Ades

Groupe Francophone des Myelodysplasies (GFM), Bobigny, France

Kathrin Nachtkamp^1*, Andrea Kuendgen^1*, Barbara Hildebrandt^2*, Norbert Gattermann³, Rainer Haas^4* and Ulrich Germing^4*

¹Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
²Human Genetics, University of Düsseldorf, Düsseldorf, Germany
³Heinrich-Heine-University, Düsseldorf, Germany
⁴Hematology, Oncology, Heinrich Heine University, Duesseldorf, Germany

Elias Jabbour^1*, Guillermo Garcia-Manero^2*, Jianqin Shan^1*, Susan O'Brien^1*, Jorge Cortes, MD¹, Farhad Ravandi^1*, Jean-Pierre J Issa³ and Hagop M Kantarjian³

¹M.D. Anderson Cancer Center, Houston, TX
²Leukemia, M.D. Anderson Cancer Center, Houston, TX
³The University of Texas M. D. Anderson Cancer Center, Houston, TX

Maurice JDL van der Vorst, MD^*, Theresia M Westers, PhD^*, Martine ED Chamuleau, MD^*, Corien Eeltink^*, Gert J Ossenkoppele, MD, PhD and Arjan A van de Loosdrecht, MD, PhD

Department of Hematology, VU University Medical Center, Amsterdam, Netherlands

Theresia M Westers, PhD^*, Canan Alhan, MD^*, Claudia Cali^*, Gert J Ossenkoppele, MD, PhD and Arjan A van de Loosdrecht, MD, PhD

Department of Hematology, VU University Medical Center, Amsterdam, Netherlands